Jiewei Chen
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- RNA modifications and cancer
- Circular RNAs in diseases
- Cancer-related gene regulation
- RNA Research and Splicing
Papers in ⓘ
-
- MicroRNA in disease regulation 5
- Oncology 15
- Cancer Immunotherapy and Biomarkers 7
- Co-authors
- Dan Xie (21 shared papers)Feng‐Wei Wang (12 shared papers)Xin‐Yuan Guan (4 shared papers)Rixin Chen (4 shared papers)Kai Han (6 shared papers)Zhizhong Pan (5 shared papers)Olivier Déas (1 shared paper)Jing‐Ping Yun (2 shared papers)
In The Last Decade
Jiewei Chen
40 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Cancer Research 603
- Molecular Biology 901
- Oncology 275
- Immunology 146
- Pathology and Forensic Medicine 115
Countries citing papers authored by Jiewei Chen
This map shows the geographic impact of Jiewei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiewei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiewei Chen more than expected).
Fields of papers citing papers by Jiewei Chen
This network shows the impact of papers produced by Jiewei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiewei Chen. The network helps show where Jiewei Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiewei Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | N6-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis Hit paper breakdown → | 2019 | 537 |
| 2 | 2017 | 55 | |
| 3 | 2021 | 54 | |
| 4 | 2019 | 50 | |
| 5 | 2015 | 49 | |
| 6 | 2021 | 43 | |
| 7 | 2020 | 37 | |
| 8 | 1997 | 34 | |
| 9 | 2015 | 33 | |
| 10 | 2024 | 31 | |
| 11 | 2018 | 30 | |
| 12 | 2022 | 28 | |
| 13 | 2019 | 27 | |
| 14 | 2017 | 26 | |
| 15 | 2014 | 26 | |
| 16 | 2020 | 17 | |
| 17 | 2021 | 16 | |
| 18 | 2021 | 16 | |
| 19 | 2018 | 15 | |
| 20 | 2024 | 14 |
About Jiewei Chen
Jiewei Chen is a scholar working on Cancer Research, Oncology, Molecular Biology, Cell Biology and Pulmonary and Respiratory Medicine, having authored 44 papers that have together received 1.3k indexed citations. Recurring topics across this work include RNA modifications and cancer (9 papers), Cancer Immunotherapy and Biomarkers (7 papers), RNA Research and Splicing (5 papers), Cancer-related gene regulation (5 papers), Metastasis and carcinoma case studies (5 papers), MicroRNA in disease regulation (5 papers), Ubiquitin and proteasome pathways (5 papers) and Circular RNAs in diseases (4 papers). The work is most often cited by research in Cancer Research (603 citations), Molecular Biology (901 citations), Oncology (275 citations), Immunology (146 citations) and Pathology and Forensic Medicine (115 citations). Jiewei Chen has collaborated with scholars based in China, Hong Kong and Germany. Frequent co-authors include Dan Xie, Feng‐Wei Wang, Xin‐Yuan Guan, Rixin Chen, Kai Han, Zhizhong Pan, Olivier Déas, Jing‐Ping Yun, Liangping Xia and Ning‐Fang Ma. Their work appears in journals such as Oncogene, Oncotarget, Cancer Management and Research, Journal of Experimental & Clinical Cancer Research and Signal Transduction and Targeted Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.